DeSci project CureX will use business income to repurchase and destroy CUX tokens
Odaily News According to official news, CureX recently announced that it will use 20% of the sales of its TRC-T product for the treatment of malignant synovial sarcoma to repurchase and destroy CUX. In the first round of repurchase, CureX purchased 100 SOL and successfully destroyed 4,259,993 CUX tokens. This operation marks that CureX has further strengthened the value and market stability of CUX tokens while promoting the application of its biotechnology products.
It is reported that the biotherapy technology TRC-T has been put into use in hospitals in Bangkok, Thailand, and the first batch of patients have received this treatment. CureX promises to continue to use part of its product revenue to repurchase and destroy CUX tokens in the future. CureX will continue to be committed to developing advanced biotechnology products to solve more disease problems and bring changes to the global healthcare industry through innovative blockchain technology.
Wallet address: 8GPiMY2cXXuKYWAoxtLK7qF1Kg4t8Bx8EiJVGDSytu3B
Destroy Hash: 2cdbUDW2ZECzBk64bd41cswjk5jPpRRTjB42kgpzWh38L6wAnJwkEe9AibNEQeHAb92QoP4DyZC577rjbrmBPqoH
